EndoQuest Advances Multicenter PARADIGM Trial
EndoQuest Robotics, Inc. has announced the activation of Baylor St. Luke’s Medical Center as a trial site for the PARADIGM Trial, which focuses on the use of robotic-assisted devices in gastrointestinal medicine. The medical center has successfully completed its first robotic ESD procedures as part of this pivotal multicenter clinical study.
HOUSTON–(BUSINESS WIRE)–EndoQuest Robotics, Inc., a pioneering leader in endoluminal robotic surgical technology, today announced that Baylor St. Luke’s Medical Center has been activated as a trial site and has successfully completed its first procedures in the PARADIGM Trial (Prospective Assessment of a Robotic Assisted Device in Gastrointestinal Medicine), a pivotal multicenter clinical study (Clinicaltrials.gov). The robotic ESD procedures were completed using EndoQuest’s Endoluminal Surgi